HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chang, K.H. Articles by McAnena, O.J. Search for Related Content PubMed Articles by Chang, K.H. Articles by McAnena, O.J. Related Collections Esophagus - cancer

J Thorac Cardiovasc Surg 2009;137:253
© 2009 The American Association for Thoracic Surgery

Letter to the Editor

En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma

Department of Surgery, Galway University Hospital, National University of Ireland, Galway, Republic of Ireland

The first 20% of the full text of this article appears below.

To the Editor:

Dr Rizzetto and colleagues¹ concluded from their retrospective review of 58 patients that en bloc esophagectomy is the surgical treatment of choice for adenocarcinoma after neoadjuvant therapy. We, however, interpret this strong statement with a degree of reservations. A larger prospective study involving 151 patients (of which 116 had adenocarcinoma) has previously demonstrated no significant difference in recurrence and survival between en bloc transthoracic and transhiatal approaches.² The discrepancy of result . . . [Full Text of this Article]